Plante Moran Financial Advisors’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$47 Buy
+4
New +$57 ﹤0.01% 1580
2018
Q3
– Sell
-6
Closed -$1K – 768
2018
Q2
$1K Sell
6
-7
-54% -$852 ﹤0.01% 754
2018
Q1
$1K Buy
13
+4
+44% +$443 ﹤0.01% 886
2017
Q4
$1K Hold
9
– – ﹤0.01% 820
2017
Q3
$1K Buy
9
+4
+80% +$388 ﹤0.01% 758
2017
Q2
$1K Hold
5
– – ﹤0.01% 777
2017
Q1
$1K Buy
+5
New +$581 ﹤0.01% 821

Other funds holding CLB

Plante Moran Financial Advisors's CLB Position: Q2 2026 in Review

Plante Moran Financial Advisors opened a new position in Core Laboratories (CLB) in Q2 2026: 4 shares worth $47. The stake represents ﹤0.01% of the portfolio and ranks #1580 among its holdings. This is a return to the name: Plante Moran Financial Advisors previously reported a position in CLB as recently as Q2 2018.

Plante Moran Financial Advisors first reported a position in CLB in Q1 2017 and has held it in 7 quarters since. The position peaked at $1K in Q2 2018. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Plante Moran Financial Advisors held 4 shares of Core Laboratories worth $47 as of Q2 2026.
  • Core Laboratories was a new Plante Moran Financial Advisors position in Q2 2026.
  • Core Laboratories made up ﹤0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #1580 holding.
  • Plante Moran Financial Advisors first reported a position in Core Laboratories in Q1 2017 and has held it in 7 quarters since.
  • Plante Moran Financial Advisors's Core Laboratories position peaked at $1K in Q2 2018.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.